These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9662327)

  • 1. A new model of cell cycle-regulated transcription: repression of the cyclin A promoter by CDF-1 and anti-repression by E2F.
    Liu N; Lucibello FC; Engeland K; Müller R
    Oncogene; 1998 Jun; 16(23):2957-63. PubMed ID: 9662327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDF-1, a novel E2F-unrelated factor, interacts with cell cycle-regulated repressor elements in multiple promoters.
    Liu N; Lucibello FC; Körner K; Wolfraim LA; Zwicker J; Müller R
    Nucleic Acids Res; 1997 Dec; 25(24):4915-20. PubMed ID: 9396796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The differential binding of E2F and CDF repressor complexes contributes to the timing of cell cycle-regulated transcription.
    Lucibello FC; Liu N; Zwicker J; Gross C; Müller R
    Nucleic Acids Res; 1997 Dec; 25(24):4921-5. PubMed ID: 9396797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle-regulated repression of B-myb transcription: cooperation of an E2F site with a contiguous corepressor element.
    Liu N; Lucibello FC; Zwicker J; Engeland K; Müller R
    Nucleic Acids Res; 1996 Aug; 24(15):2905-10. PubMed ID: 8760872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
    Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P
    Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex.
    Le Cam L; Polanowska J; Fabbrizio E; Olivier M; Philips A; Ng Eaton E; Classon M; Geng Y; Sardet C
    EMBO J; 1999 Apr; 18(7):1878-90. PubMed ID: 10202151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interaction of E2F/Rb family members with factor binding to co-repressor element on B-myb and E2F1 promoters].
    Nakajima Y
    Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):172-88. PubMed ID: 9711036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
    Bennett JD; Farlie PG; Watson RJ
    Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2Fs link the control of G1/S and G2/M transcription.
    Zhu W; Giangrande PH; Nevins JR
    EMBO J; 2004 Nov; 23(23):4615-26. PubMed ID: 15510213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
    Hiyama H; Iavarone A; Reeves SA
    Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDP/cut is the DNA-binding subunit of histone gene transcription factor HiNF-D: a mechanism for gene regulation at the G1/S phase cell cycle transition point independent of transcription factor E2F.
    van Wijnen AJ; van Gurp MF; de Ridder MC; Tufarelli C; Last TJ; Birnbaum M; Vaughan PS; Giordano A; Krek W; Neufeld EJ; Stein JL; Stein GS
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11516-21. PubMed ID: 8876167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of E2F1 in mesangial cell proliferation in vitro.
    Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
    Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
    Johnson DG
    Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter.
    Hsiao KM; McMahon SL; Farnham PJ
    Genes Dev; 1994 Jul; 8(13):1526-37. PubMed ID: 7958837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1.
    Watanabe G; Albanese C; Lee RJ; Reutens A; Vairo G; Henglein B; Pestell RG
    Mol Cell Biol; 1998 Jun; 18(6):3212-22. PubMed ID: 9584162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the Cdc25A gene by the human papillomavirus Type 16 E7 oncogene.
    Katich SC; Zerfass-Thome K; Hoffmann I
    Oncogene; 2001 Feb; 20(5):543-50. PubMed ID: 11313986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The periodic down regulation of Cyclin E gene expression from exit of mitosis to end of G(1) is controlled by a deacetylase- and E2F-associated bipartite repressor element.
    Polanowska J; Fabbrizio E; Le Cam L; Trouche D; Emiliani S; Herrera R; Sardet C
    Oncogene; 2001 Jul; 20(31):4115-27. PubMed ID: 11464278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
    Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR
    DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.